血管内皮生长因子121(VEGF121)重组蛋白
Recombinant Vascular Endothelial Growth Factor 121 (VEGF121)
- 编号RPB851Mu01
- 物种Mus musculus (Mouse,小鼠) 相同的名称,不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位细胞膜, 分泌
- 预测分子量19.7kDa
- 实际分子量20kDa(差异分析请参阅说明书)
- 片段与标签Ala27~Arg146 with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 97%
- 等电点7.2
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1032 ¥ 2580 ¥ 5160 ¥ 15480 ¥ 38700
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Mus musculus (Mouse,小鼠) | 应用(仅供研究使用,不用于临床诊断!) |
RPB851Mu01 | 血管内皮生长因子121(VEGF121)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB851Mu01 | 血管内皮生长因子121(VEGF121)多克隆抗体 | WB; IHC; ICC; IP. |
SEB851Mu | 血管内皮生长因子121(VEGF121)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
MEB851Mu | 血管内皮生长因子121(VEGF121)检测试剂盒(酶联免疫吸附试验法,小样本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB851Mu | 血管内皮生长因子121(VEGF121)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
KSB851Mu01 | 血管内皮生长因子121(VEGF121)检测试剂盒DIY材料(酶联免疫吸附试验法) | 自己动手制作ELISA试剂盒的主要材料 |
参考文献
杂志 | 参考文献 |
Oncogene | Elevated PLGF contributes to small-cell lung cancer brain metastasis [PubMed: 22797069] |
BMC Cancer | VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma [Pubmed:29747600] |
JOURNAL OF CLINICAL NEUROSCIENCE | A pediatric case of anaplastic astrocytoma with a gliomatosis cerebri; the growth pattern and changes in serum VEGF-121 levels after bevacizumab treatment [Pubmed: 33222957] |
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE | Associations between VEGF isoforms and impending retinopathy of prematurity [Pubmed: 32737903] |
international journal of oncology | Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma [Pubmed: 32377747] |
留言咨询